Added to YB: 2017-07-05
Pitch date: 2017-07-05
BIVV:US [bearish]
Bioverativ Inc.
-94.19%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bioverativ Inc. is a biopharmaceutical company that engages in the development of therapies and programs for hemophilia, cold agglutinin disease, sickle cell disease, beta thalassemia, and other blood disorders.
Market Cap
$11.4B
Pitch Price
$54.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
32.01
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Bioverativ, Inc. BIVV:US
A summary for this pitch has not been created yet.
Read full article (0 min)